Orgenesis Approved for Additional European Grant for Further Development of its Type 1 Diabetes Program Biotech Investing
Corbus Pharmaceuticals Receives FDA Approval for Open-Label Extension to Its Phase 2 Trial of Resunab for Systemic Sclerosis Life Science Investing
HTG Molecular Diagnostics Announces Distribution Agreements with Gamidor in Israel and Durviz in Spain and Portugal Medical Device Investing
NOVADAQ to Release First Quarter 2016 Financial Results on April 27, 2016 – Conference Call to Follow Medical Device Investing
TG Therapeutics, Inc. Announces Issuance of Composition of Matter Patent for TG-1101 in the United States Biotech Investing
Proteon Therapeutics Announces Publication in the Journal of Cardiovascular Pharmacology of Promising Nonclinical Results for Vonapanitase in Peripheral Artery Disease Life Science Investing
Arrowhead Pharmaceuticals Presents Promising ARC-520 Hepatitis B Data at The International Liver Congress™ 2016 Genetics Investing
vTv Therapeutics Announces Presentations on its Diabetes Product Candidates TTP273 and TTP399 at the Keystone Symposia on New Therapeutics for Diabetes and Obesity Biotech Investing
Inova Translational Medicine Institute Partners with Translational Software on MediMap™, an Optional Newborn Pharmacogenomic Test at Inova Women’s Hospital Genetics Investing
Research Validates Preimplantation Genetic Diagnosis for Aneuploidy (PGD-A) as a Valuable Tool in Identifying Viable Embryos During In Vitro Fertilization (IVF) Genetics Investing
Remedy Pharmaceuticals Announces Two Oral Presentations on Results of CNS-Related Edema Trial At Annual American Academy of Neurology Meeting Life Science Investing
BriaCell Files a Patent Application to Protect Additional Cancer Vaccines With Genetic Features Thought to Promote Strong Anti-Tumor Activity Biotech Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
